NCT06357962

Brief Summary

Cervical ripening is a medical treatment that can cause physical or emotional discomfort in pregnant women and is not without risks. This is a pilot study to assess feasibility and calculate the number of participants necessary for a complete clinical trial. The aim is to evaluate whether acupuncture can reduce the need for treatment (cervical ripening) in pregnant women at low or intermediate risk. Participants will be divided into two groups: one group will receive acupuncture, and the other will receive a simulated treatment of acupuncture.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 5, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 10, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

May 22, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 16, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 19, 2025

Completed
Last Updated

December 1, 2025

Status Verified

November 1, 2025

Enrollment Period

10 months

First QC Date

April 5, 2024

Last Update Submit

November 24, 2025

Conditions

Keywords

Cervical RipeningAcupuncture Therapy

Outcome Measures

Primary Outcomes (1)

  • Pharmacological induction

    Percentage of pregnant women who have undergone pharmacological induction to initiate labor.

    Birth date

Secondary Outcomes (5)

  • Change on score of Bishop scale

    Birth date

  • Onset of spontaneous labor

    Birth date

  • Duration of induction period Duration of the induction period Duration of the induction period Duration of the induction period

    Birth date

  • Duration of labor period

    Birth date

  • Satisfaction of pregnants

    Birth date

Study Arms (2)

Acupuncture

EXPERIMENTAL

This group will receive sessions the study intervention (semi-permanent acupuncture)

Other: Semi-permanent acupuncture

Control

SHAM COMPARATOR

This group will receive a sham treatment of semi-permanent acupuncture

Other: Sham of semi-permanent acupuncture

Interventions

These are sessions that last approximately one hour. The selection of points will be based on the energy diagnosis made during the first visit. In some cases, a point may be changed depending on progress. During the session, an interrogation will be conducted to assess symptoms and signs of the condition, and to evaluate if there have been any adverse reactions to the previous session. At the end of the visit, semi-permanent acupuncture will be applied to the selected points.

Acupuncture

A simulated semi-permanent acupuncture session will be conducted, consisting of specific placebo materials without needles and without stimulation for a few minutes. These points will not correspond to any acupuncture point and will be located on the hands, feet, and back. Stickers without pins will be applied, but never in critical points related to contraction stimulation or cervical ripening.

Control

Eligibility Criteria

AgeUp to 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThe participants will be pregnant women
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Anticipated delivery at the study center.
  • Ability to collaborate in necessary evaluations.
  • Legal capacity to provide informed consent.

You may not qualify if:

  • Pregnancy with high or very high risk as described by the Pregnancy and Childbirth Monitoring Protocols of the Department of Health of Catalonia
  • History of cesarean delivery.
  • Language barrier preventing collaboration in study procedures.
  • Cognitive or affective pathology limiting the ability to collaborate with study procedures.
  • Participation in another clinical trial involving an experimental intervention during the period of this trial and/or establishing a visit frequency incompatible with this trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Consorci Sanitari Alt Penedes i Garraf

Vilafranca del Penedès, Barcelona, 08720, Spain

Location

MeSH Terms

Conditions

Pregnancy Complications

Condition Hierarchy (Ancestors)

Female Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Gloria Villena

    CSAPG

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2024

First Posted

April 10, 2024

Study Start

May 22, 2024

Primary Completion

March 16, 2025

Study Completion

April 19, 2025

Last Updated

December 1, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

IPD (without personal identification data) could be shared by requirement from other researchers after the end of the study, and only for research purposes and previous approval of promotor center of the study (CSAPG). Anyway, Spanish and European Union legal policy about data protection will strictly be followed (IPD will not be transferred outside European Union).

Shared Documents
STUDY PROTOCOL
Time Frame
After publication of main results of the study.
Access Criteria
IPD will be shared only for scientific research purposes and following the Spanish and European Union normative law about data protection. The requirements will be directed to the IP of the study. The IP will evaluate the request to verify and evaluate the data that is requested and the purposes for which it is requested. Next, the IP will transfer the request to the promotor center the study for the final decision.

Locations